CD276 and glioma: Tang et al. evaluated the antitumor activities of CAR-T targeting B7-H3 in both primary glioma cells and GBM cell lines; they also observed significantly longer median survival in the CAR-T group compared to the control group in an orthotropic GBM model (Tang et al., 2019).